
|Articles|November 13, 2018
AAO Gene Therapy Street Team
Advertisement
Karmen Trzupek discusses the complex interpretation of genetic test results
In his gene therapy break with the experts , Mark Pennesi compared genetic testing for IRDs to fishing
Dominik Fischer presents gene therapy proof-of-concept results in choroideremia
Vinit Mahajan explains that RPE65 mutation subtype was unrelated to outcomes in the Luxturna gene therapy trial
Christine Kay summarizes her jam packed session on gene therapy
Birgit Lorenz looks ahead to ISGEDR 2019 where gene therapy will be a major topic
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
The Residency Report: Cardiovascular risk scores as a window into ocular disease
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5





















